Rallybio reports positive data in its clinical program for the prevention of fetal and neonatal alloimuune thrombocytopenia (FNAIT)
Rallybio today announced data from its ongoing Phase 1/2 study of RLYB211 showing significant benefit over placebo.
Cipia announces IPO
Cipia today announced that it has raised $22M as part of the company’s initial public offering (IPO).
Valens goes public on the New York Stock Exchange.
Valens Semiconductor, Ltd. (“Valens”), a premier provider of high-speed connectivity solutions for the audio-video and automotive markets, and PTK Acquisition Corp. (NYSE: PTK) (“PTK”), a special purpose acquisition company, today announced the completion of their previously announced business combination (the “Business Combination”).
Spire to expand footprint by acquiring exactEarth
Spire Global, Inc. (NYSE: SPIR), a leading provider of space-based data, analytics and space services, and exactEarth Ltd. (TSX: XCT) (“exactEarth”) announced today that the companies have entered into a definitive arrangement agreement under which Spire will acquire exactEarth for approximately US$161.2 million (CAD$204.2 million) in cash and stock, which implies ~9.1x exactEarth’s Enterprise Value to LTM revenue.
Spire goes public through SPAC.
Spire Global, Inc. (“Spire” or the “Company”) a leading global provider of space-based data, analytics and space services, today announced it has completed its previously announced business combination with NavSight Holdings, Inc. (NYSE: NSH) (“NavSight”) to take Spire public.
